1. Home
  2. CPSS vs ALEC Comparison

CPSS vs ALEC Comparison

Compare CPSS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

N/A

Current Price

$8.33

Market Cap

189.3M

Sector

Finance

ML Signal

N/A

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$1.98

Market Cap

204.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
ALEC
Founded
1991
2013
Country
US
US
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.3M
204.1M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
CPSS
ALEC
Price
$8.33
$1.98
Analyst Decision
Hold
Analyst Count
0
7
Target Price
N/A
$3.33
AVG Volume (30 Days)
14.3K
773.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.15
EPS
0.59
N/A
Revenue
$393,506,000.00
$100,600,000.00
Revenue This Year
$139.62
N/A
Revenue Next Year
$10.58
N/A
P/E Ratio
$14.13
N/A
Revenue Growth
11.79
3.60
52 Week Low
$6.67
$0.87
52 Week High
$11.42
$3.40

Technical Indicators

Market Signals
Indicator
CPSS
ALEC
Relative Strength Index (RSI) 42.56 59.92
Support Level $8.27 $1.84
Resistance Level $9.20 $2.03
Average True Range (ATR) 0.26 0.12
MACD -0.02 -0.01
Stochastic Oscillator 6.89 75.41

Price Performance

Historical Comparison
CPSS
ALEC

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Share on Social Networks: